Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

eIF-4E expression and its role in malignancies and metastases

Abstract

The contribution of the mRNA cap-binding protein, eIF-4E, to malignant transformation and progression has been illuminated over the past decade. eIF-4E overexpression has been demonstrated in human tumors of the breast, head and neck, colon, prostate, bladder, cervix and lung, and has been related to disease progression. Overexpression of eIF-4E in experimental models dramatically alters cellular morphology, enhances proliferation and induces cellular transformation, tumorigenesis and metastasis. Conversely, blocking eIF-4E function by expression of antisense RNA, or overexpression of the inhibitory eIF-4E binding proteins (4E-BPs), suppresses cellular transformation, tumor growth, tumor invasiveness and metastasis. Although eIF-4E regulates the recruitment of mRNA to ribosomes, and thereby globally regulates cap-dependent protein synthesis, eIF-4E contributes to malignancy by selectively enabling the translation of a limited pool of mRNAs – those that generally encode key proteins involved in cellular growth, angiogenesis, survival and malignancy (e.g. cyclin D1, c-myc, vascular endothelial growth factor, matrix metalloprotease 9). A deeper understanding of the role of eIF-4E in regulating the translation of the diverse gene products involved in all aspects of malignancy will improve the capacity to exploit eIF-4E as a therapeutic target and as a marker for human cancer progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Abid R, Li Y and De Benedetti A . (1999). J. Biol. Chem., 274, 35991–35998.

  • Agrawal D, Hauser P, McPherson F, Dong F, Garcia A and Pledger WJ . (1996). Mol. Cell. Biol., 16, 4327–4336.

  • Anthony B, Carter P and De Benedetti A . (1996). Int. J. Cancer, 65, 858–863.

  • Arrick BA, Lee AL, Grendell RL and Derynck R . (1991). Mol. Cell. Biol., 11, 4306–4313.

  • Auvinen M, Laine A, Paasinen-Sohns A, Kangas A, Kangas L, Saksela O, Andersson LC and Holtta E . (1997). Cancer Res., 57, 3016–3025.

  • Bamford RN, Battiata AP, Burton JD, Sharma H and Waldmann TA . (1996). Proc. Natl. Acad. Sci. USA, 93, 2897–2902.

  • Baserga R . (1990). Cancer Res., 50, 6769–6771.

  • Battey J, Moulding C, Taub R, Murphy W, Stewart T, Potter H, Lenir G and Leder P . (1983). Cell, 34, 779–787.

  • Berkel HJ, Turbat-Herrera EA, Shi R and De Benedetti A . (2001). Cancer Epidemiol. Biomarkers Prev., 10, 663–666.

  • Bommer UA, Lazaris-Karatzas A, De Benedetti A, Nurnberg P, Benndorf R, Bielka H and Sonenberg N . (1994). Cell Mol. Biol. Res., 40, 633–641.

  • Brown CY, Mize GJ, Pineda M, George DL and Morris DR . (1999). Oncogene, 18, 5631–5637.

  • Calkhoven CF, Muller C and Leutz A . (2000). Genes Dev., 14, 1920–1932.

  • Capoulade C, Bressac-de Paillerets B, Lefrere I, Ronsin M, Feunteun J, Tursz T and Wiels J . (1998). Oncogene, 16, 1603–1610.

  • Carter PS, Jarquin M and De Benedetti A . (1999). Oncogene, 18, 4326–4335.

  • Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB and Jensen RH . (1996). Cancer Res., 56, 3091–3102.

  • Child SJ, Miller MK and Geballe AP . (1999). Int. J. Biochem. Cell Biol., 31, 201–213.

  • Crew JP, Fuggle S, Bicknell R, Cranston DW, De Benedetti A and Harris AL . (2000). Br. J. Cancer, 82, 161–166.

  • Darveau A, Pelletier J and Sonenberg N . (1985). Proc. Natl. Acad. Sci. USA, 82, 2315–2319.

  • De Benedetti A, Joshi B, Graff JR and Zimmer SG . (1994). Mol. Cell. Differ., 2, 347–371.

  • De Benedetti A, Joshi-Barve S, Rinker-Schaeffer C and Rhoads RE . (1991). Mol. Cell. Biol., 11, 5435–5445.

  • De Benedetti A and Rhoads RE . (1990). Proc. Natl. Acad. Sci. USA, 87, 8212–8216.

  • DeFatta RJ, Chervenak RP and De Benedetti A . (2002b). Cancer Gene Ther., 9, 505–512.

  • DeFatta R and De Benedetti A . (2003). Int. J. Oncol., 23, 1707–1713.

  • DeFatta RJ, Li Y and De Benedetti A . (2002a). Cancer Gene Ther., 9, 573–578.

  • DeFatta RJ, Nathan CO and De Benedetti A . (2000). Laryngoscope, 110, 928–933.

  • DeFatta RJ, Turbat-Herrera EA, Li BDL, Anderson W and De Benedetti A . (1999). Int. J. Cancer., 80, 518–522.

  • Duncan R, Milburn SC and Hershey JB . (1987). J. Biol. Chem., 262, 380–388.

  • Fagan RJ, Lazaris-Karatzas A, Sonenberg N and Rozen R . (1991). J. Biol. Chem., 266, 16518–16523.

  • Folkman J and Klagsbrun M . (1987). Science, 235, 442–447.

  • Franklin S, Pho T, Abreo F, Nassar R, De Benedetti A, Stucker F and Nathan CA . (1999). Arch. Otolaryngol. Head Neck Surg., 125, 177–182.

  • Gao M, Rychlik W and Rhoads RE . (1998). J. Biol. Chem., 273, 4622–4628.

  • Geballe AP and Morris DR . (1994). TIBS, 19, 150–164.

  • Gingras AC, Raught B and Sonenberg N . (1999). Annu. Rev. Biochem., 68, 913–963.

  • Gingras AC, Raught B and Sonenberg N . (2001). Genes Dev., 15, 807–826.

  • Gospodarowicz D, Neufield G and Schweiger L . (1987). J. Cell. Physiol., 5, 15–26.

  • Graff JR . (2002). Expert. Opin. Ther. Targets, 6, 103–113.

  • Graff JR, Boghaert ER, De Benedetti A, Tudor DM and Zimmer SG . (1995). Int. J. Cancer, 60, 255–263.

  • Graff JR, De Benedetti A, Olson JW, Tamez P, Casero RA and Zimmer SG . (1997). Biochem. Biophys. Res. Com., 240, 15–20.

  • Graff JR and Zimmer SG . (2003). Clin. Exp. Metast., 20, 265–273.

  • Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW and Geissler EK . (2002). Nat. Med., 8, 128–135.

  • Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.

  • Hengst L and Reed SI . (1996). Science, 271, 1861–1864.

  • Hensold JO, Stratton CA and Barth C . (1997). Nucleic Acids Res., 25, 2869–2876.

  • Hernandez-Munoz I, Benet M, Calero M, Jimenez M, Diaz R and Pellicer A . (2003). Cancer Res., 63, 4188–4195.

  • Hidalgo M and Rowinsky EK . (2000). Oncogene, 19, 6680–6686.

  • Hiremath LS, Webb NR and Rhoads RE . (1985). J. Biol. Chem., 260, 7843–7849.

  • Holmlund JT, Monia BP, Kwoh TJ and Dorr FA . (1999). Curr. Opin. Mol. Ther., 1, 372–385.

  • Hoover DS, Wingett DG, Zhang J, Reeves R and Magnuson NS . (1997). Cell Growth Differ., 8, 1371–1380.

  • Huang S, Bjornsti MA and Houghton PJ . (2003). Cancer Biol. Ther., 2, 222–232.

  • Jiang Y and Muschel RJ . (2002). Cancer Res., 62, 1910–1914.

  • Jones RM, Branda J, Johnston KA, Polymenis M, Gadd M, Rustgi A, Callanan L and Schmidt EV . (1996). Mol. Cell. Biol., 16, 4754–4764.

  • Kerekatte V, Smiley K, Hu B, Smith A, Gelder F and De Benedetti A . (1995). Int. J. Cancer, 64, 27–31.

  • Kevil C, Carter P, Hu B and De Benedetti A . (1995). Oncogene, 11, 2339–2348.

  • Kevil C, De Benedetti A, Payne KD, Coe LL, Laroux S and Alexander S . (1996). Int. J. Cancer, 65, 785–790.

  • Klagsbrun M, Sasse J, Sullivan R and Smith JA . (1986). Proc. Natl. Acad. Sci. USA, 83, 2448–2452.

  • Klein PS and Melton DA . (1994). Science, 265, 803–805.

  • Koch G, Bilello JA, Kruppa J and Koch F . (1980). Ann. NY Acad. Sci., 339, 280–306.

  • Koromilas AE, Lazaris-Karatzas A and Sonenberg N . (1992). EMBO J., 11, 4153–4158.

  • Kozak M . (1991). J. Cell Biol., 115, 887–903.

  • Landers JE, Cassel SL and George DL . (1997). Cancer Res., 57, 3562–3568.

  • Landers JE, Haines DS, Strauss III JF and George DL . (1994). Oncogene, 9, 2745–2750.

  • Lazaris-Karatzas A, Montine KS and Sonenberg N . (1990). Nature, 345, 544–547.

  • Lazaris-Karatzas A, Smith MR, Frederickson RM, Jaramillo ML, Liu YL, Kung HF and Sonenberg N . (1992). Genes Dev., 6, 1631–1642.

  • Lazaris-Karatzas A and Sonenberg N . (1992). Mol. Cell. Biol., 12, 1234–1238.

  • Leung DW, Cachianes G, Kuang WJ, Goddel DV and Ferrara N . (1989). Science, 246, 1306–1309.

  • Li Y, DeFatta R, Anthony C, Sunavala G and De Benedetti A . (2001). Oncogene, 20, 726–738.

  • Li BD, Gruner JS, Abreo F, Johnson LW, Yu H, Nawas S, McDonald JC and DeBenedetti A . (2002). Ann. Surg., 235, 732–738.

  • Li BDL, Liu L, Dawson M and De Benedetti A . (1997). Cancer, 79, 2385–2389.

  • Li BDL, McDonald J, Nassar R and De Benedetti A . (1998). Ann. Surg. Soc., 227, 756–762.

  • Li S, Takasu T, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Bitterman PB and Polunovsky VA . (2003). J. Biol. Chem., 278, 3015–3022.

  • Lodish HF . (1974). Nature, 251, 385–388.

  • Luan FL, Ding R, Sharma VK, Chon WJ, Lagman M and Suthanthiran M . (2003). Kidney Int., 63, 917–926.

  • Manzella JM, Rychlik W, Rhoads RE, Hershey LW and Blackshear PJ . (1991). J. Biol. Chem., 266, 2383–2389.

  • Marth JD, Overell RW, Meier KE, Krebs EG and Perlmutter RM . (1988). Nature, 332, 171–173.

  • Mathews-Greer J, De Benedetti A, Tucker A, Dempsey S, Black D and Turbat-Herrera E . (2002). J. Appl. Res., 2, 77–86.

  • Miyagi Y, Sugiyama A, Asai A, Okazaki T, Kuchino Y and Kerr S . (1995). Cancer Lett., 91, 247–252.

  • Morley SJ . (1994). Mol. Biol. Rep., 19, 221–231.

  • Nagata S . (1997). Cell, 88, 355–365.

  • Nathan CA, Carter P, Liu L, Li B, Abreo F, Tudor A, Zimmer S and De Benedetti A . (1997a). Oncogene, 15, 1087–1095.

  • Nathan CA, Liu L, Li B, Nandy I, Abreo F and De Benedetti A . (1997b). Oncogene, 15, 579–584.

  • Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R, Frost P, Gibbons JJ, Wu H and Sawyers CL . (2001). Proc. Natl. Acad. Sci. USA., 98, 10314–10319.

  • Nilsson FC, Gammeltoft S and Christiansen J . (1990). J. Biol. Chem., 265, 13431–13434.

  • Noma T, Glick AB, Geiser AG, O’Reilly MA, Miller J, Roberts AB and Sporn MB . (1991). Growth Factors, 4, 247–255.

  • Pardo OE, Arcaro A, Salerno G, Raguz S, Downward J and Seckl MJ . (2002). J. Biol. Chem., 277, 12040–12046.

  • Pelletier J and Sonenberg N . (1987). Biochem. Cell Biol., 65, 576–581.

  • Peralba JM, DeGraffenried L, Friedrichs W, Fulcher L, Grunwald V, Weiss G and Hidalgo M . (2003). Clin. Cancer Res., 9, 2887–2892.

  • Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J, Neshat M, Wang H, Yang L, Gibbons J, Frost P, Dreisbach V, Blenis J, Gaciong Z, Fisher P, Sawyers C, Hedrick-Ellenson L and Parsons R . (2001). Proc. Natl. Acad. Sci. USA, 98, 10320–10325.

  • Polunovsky VA, Gingras AC, Sonenberg N, Peterson M, Tan A, Rubins JB, Manivel JC and Bitterman PB . (2000). J. Biol. Chem., 275, 24776–24780.

  • Polunovsky VA, Rosenwald IB, Tan AT, White J, Chiang L, Sonenberg N and Bitterman PB . (1996). Mol. Cell. Biol., 16, 6573–6581.

  • Prats H, Kaghad M, Prats AP, Klagsbrun M, Lelias JM, Liazun P, Chalon P, Tauber JP, Amalric F, Smith JA and Caput D . (1989). Proc. Natl. Acad. Sci. USA, 86, 1836–1840.

  • Pyronnet S, Pradayrol L and Sonenberg N . (2000). Mol. Cell., 5, 607–616.

  • Ramaswamy S, Ross KN, Lander ES and Golub TR . (2003). Nat. Gen., 33, 49–54.

  • Rao CD, Pech M, Robbins KC and Aaroson SA . (1988). Mol. Cell. Biol., 8, 284–292.

  • Raught B, Gingras AC, James A, Medina D, Sonenberg N and Rosen JM . (1996). Cancer Res., 56, 4382–4386.

  • Reddy KS and Sulkova V . (1997). Cancer Genet. Cytogenet., 95, 206–209.

  • Rhoads RE . (1988). TIBS, 13, 52–56.

  • Rhoads RE . (1993). J. Biol. Chem., 266, 3017–3020.

  • Rhoads RE, Joshi-Barve S and Rinker-Schaeffer C . (1993). Prog. Nucleic Acid Res. Mol. Biol., 46, 183–219.

  • Rinker-Schaeffer CW, Graff JR, De Benedetti A, Zimmer SG and Rhoads RE . (1993). Int. J. Cancer, 55, 841–847.

  • Rosenwald IB, Chen JJ, Wang ST, Savas L, London IM and Pullman J . (1999). Oncogene, 18, 2507–2517.

  • Rosenwald IB, Hutzler MJ, Wang S, Savas L and Fraire AE . (2001). Cancer, 92, 2164–2171.

  • Rosenwald IB, Karatzas A, Sonenberg N and Schmidt EV . (1993). Mol. Cell. Biol., 13, 7358–7363.

  • Rosenwald EB, Kaspar R, Rosseau D, Gehrke L, Leboulch P, Chen JJ, Schmidt EV, Sonenberg N and London IM . (1995). J. Biol. Chem., 270, 21176–21180.

  • Rousseau D, Kaspar R, Rosenwald I, Gerke L and Sonenberg N . (1996). Proc. Natl. Acad. Sci. USA, 93, 1065–1070.

  • Saito H, Hayday AC, Wiman K, Hayward WS and Tonegawa S . (1983). Proc. Natl. Acad. Sci. USA, 80, 7476–7480.

  • Scheper GC and Proud CG . (2002). Eur. J. Biochem., 269, 5350–5359.

  • Schindler R, Clark BD and Dinarello CA . (1990). J. Biol. Chem., 265, 10232–10237.

  • Scott PAE, Smith K, Poulsom R, De Benedetti A, Bicknell R and Harris AL . (1998). Br. J. Cancer, 77, 2120–2128.

  • Seki N, Takasu T, Mandai K, Nakata M, Saeki H, Heike Y, Takata I, Segawa Y, Hanafusa T and Eguchi K . (2002). Clin. Cancer Res., 8, 3046–3053.

  • Shantz LM, Hu RH and Pegg AE . (1996). Cancer Res., 56, 3265–3269.

  • Shantz LM and Pegg AE . (1994). Cancer Res., 54, 2313–2316.

  • Shantz LM, Viswanath R and Pegg AE . (1994). Biochem. J., 302, 765–772.

  • Shevde LA and Welch DR . (2003). Cancer Lett., 198, 1–20.

  • Short JD and Pfarr CM . (2002). J. Biol. Chem., 277, 32697–32705.

  • Sillje HHW and Nigg EA . (2001). Curr. Biol., 11, 1068–1073.

  • Simizu S, Ishida K, Wierzba MK, Sato TA and Osada H . (2003). Cancer Lett., 193, 83–89.

  • Smith R, Peters G and Dickson C . (1988). EMBO J., 7, 1013–1022.

  • Stacey DW . (2003). Curr. Opin. Cell. Biol., 15, 158–163.

  • Stein I, Itin A, Einat P, Skaliter R, Grossman Z and Keshet E . (1998). Mol. Cell. Biol., 18, 3112–3119.

  • Stonely M, Paulin FEM, Le Quesne JPC, Chappell SA and Willis AE . (1998). Oncogene, 16, 423–428.

  • Tamm I, Dorken B and Hartmann G . (2001). Lancet, 358, 489–497.

  • Tan A, Bitterman P, Sonenberg N, Peterson M and Polunovsky V . (2000). Oncogene, 19, 1437–1447.

  • Thach RE . (1992). Cell, 22, 177–180.

  • Theillet C, Le Roy X and De Lapeyriere O . (1989). Oncogene, 4, 915–922.

  • Vagner S, Gensac MC, Maret A, Bayard F, Amalric F, Prats H and Prats AC . (1995). Mol. Cell. Biol., 15, 35–44.

  • Wang S, Rosenwald IB, Hutzler MJ, Pihan GA, Savas L, Chen JJ and Woda BA . (1999). Am. J. Pathol., 155, 247–255.

  • Wang C and Stiles CD . (1993). Cell Growth Differ., 4, 871–877.

  • Wellstein A and Lippman ME . (1991). Molecular Foundations of Oncology, Broder S (ed). Williams & Wilkins: pp 403–417.

  • Wellstein A, Lupu R and Zugmaier G . (1990). Cell Growth Differ., 1, 63–71.

  • Williams J, De Benedetti A, Acree T, Veanable T and Eastham J . (1998). AACR Special Conference ‘Angiogenesis and Cancer’. Orlando, FL.

    Google Scholar 

  • Wood MW, Van Dongen HM and Van Dongen AM . (1996). J. Biol. Chem., 271, 8115–8120.

  • Yang YJ, Zhang YL, Li X, Dan HL, Lai ZS, Wang JD, Wang QY, Cui HH, Sun Y and Wang YD . (2003). World J. Gastroenterol., 9, 1707–1712.

  • Zerial M, Toschi L, Ryseck RP, Schuermann M, Mueller R and Bravo R . (1989). EMBO J., 8, 805–813.

  • Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW . (1999). Cancer Res., 59, 5830–5835.

  • Zimmer SG, DeBenedetti A and Graff JR . (2000). Anticancer Res., 20, 1343–1352.

Download references

Acknowledgements

This work was supported by Grant BCTR0100512 from the Susan G Komen Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arrigo De Benedetti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Benedetti, A., Graff, J. eIF-4E expression and its role in malignancies and metastases. Oncogene 23, 3189–3199 (2004). https://doi.org/10.1038/sj.onc.1207545

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207545

Keywords

This article is cited by

Search

Quick links